Beacon Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Beacon Financial Advisory's VRTX Position: Q2 2026 in Review
Beacon Financial Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 1.2% in Q2 2026, selling an estimated $3.1K and leaving 562 shares worth $279K. The position accounts for 0.06% of the portfolio, ranked #347.
Beacon Financial Advisory first reported a position in VRTX in Q4 2023 and has held it in 7 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Beacon Financial Advisory held 562 shares of Vertex Pharmaceuticals worth $279K as of Q2 2026.
- Beacon Financial Advisory sold 7 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.1K.
- Vertex Pharmaceuticals made up 0.06% of Beacon Financial Advisory's portfolio in Q2 2026, its #347 holding.
- Beacon Financial Advisory first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Beacon Financial Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.